PLA2R1 and focal segmental glomerulosclerosis: Only one patient with a clinical and histological diagnosis compatible with FSGS had a low titer of anti-PLA2R (23 RU/mL) result by ELISA and a negative anti-PLA2R IFI test, which may be considered a false positive [23].